Analysis of Apolipoproteins

Schaefer EJ Heaton WH Wetzel MG Brewer HB Jr. Plasma apolipoprotein A-I absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis 1982; 2: 16–26.

Dolphin PJ. Lipolytic enzymes and the role of apolipoproteins in the regulation of their activity. In: Rosseneu M , ed. Structure and Function of Apolipoproteins. Boca Raton: CRC Press, 1992: 295–362.

Fielding CJ Shore VG Fielding FE. A protein cofactor of lecithin: cholesterol acyl transferase. Biochem Biophys Res Commun 1972; 46: 1493–8.

Brown MS Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34–47.

Tybjærg-Hansen A Humphries SE. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolaemia and premature coronary artery disease. Atherosclerosis 1992; 96: 91–107.

Mahley RW Rall SC Jr. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR Beaudet AL Sly WS Valle D , eds. Metabolic Basis of Inherited Disease, 6th edn. New York: McGraw Hill, 1989: 1195–213.

Bhatnagar D Durrington PN. Clinical value of apolipoprotein measurements. Ann Clin Biochem 1991; 28: 427–37.

Avogaro P Bon G Bittolo Cazzolato G Qunici GB. Are apolipoproteins better predictors than lipids for atherosclerosis? Lancet 1979; i: 901–3.

Sniderman AD Shapiro S Marpole D Skinner B Teng B Kwiterovich PO. Association of coronary atherosclerosis with hyperbetalipoproteinaemia (increased protein but normal cholesterol levels in human plasma low density (b) lipoproteins). Proc Natl Acad Sci USA 1980; 77: 604–8.

Riesen WF Mordasini R Salzmann C Theler A Gurtner HP. Apoproteins and lipids as discriminators of severity of coronary heart disease. Atherosclerosis 1980; 37: 157–62.

Brunzell JD Sniderman AD Albers JJ Kwiterovich PO. Apoprotein B and AI and coronary heart disease in humans. Arteriosclerosis 1984; 4: 79–83.

Durrington PN Hunt L Ishola M Kane J Stephens WP. Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction. Br Heart J 1986; 56: 206–12.

Durrington PN Ishola M Hunt L Arrol S Bhatnagar D. Apolipoprotein(a), AI, and B and parental history in men with early onset ischaemic heart disease. Lancet 1988; i: 1070–3.

Stampfer MJ Sacks FM Salvini S Willett WC Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991; 325: 373–81.

Wald NJ Law M Watt HC Wu T Bailey A Johnson AM Apolipoproteins and ischaemic heart disease: implications for screening. Lancet 1994; 343: 75–9.

Scanu AM Fless GM. Lipoprotein(a). Heterogeneity and biological relevance. J Clin Invest 1990; 85: 1709–15.

Mbewu AD Durrington PN. Lipoprotein(a): structure, properties and possible involvement in thrombogenesis and atherosclerosis. Atherosclerosis 1990; 85: 1–14.

Guyton JR Dahlen GH Patsch W Kautz JA Gotto AM Jr. Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arteriosclerosis 1985; 5: 265–72.

Armstrong VW Cremer P Eberle E Manke A Schulze F Wieland H The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 1986; 62: 249–57.

Seed M Hoppichler F Reaveley D McCarthy S Thompson GR Boerwinkle E Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolaemia. N Engl J Med. 1990; 322: 1494–9.

Scott J. Lipoprotein(a). Thrombotic and atherogenic. BMJ 1991; 303: 663–4.

Laker MF Game FL. Laboratory investigation of dyslipoproteinaemias. In: Betteridge DJ Illingworth DR Shepherd J , eds. Lipoprotein Metabolism and Disorders. London: Edward Arnold (in press).

Breslow JL. Familial disorders of high density lipoprotein metabolism. In: Scriver CR Beaudet AL Sly WS Valle D , eds. Metabolic Basis of Inherited Disease, 6th edn. New York: McGraw Hill, 1989: 1251–66.

Assmann G Schmitz G Brewer HB Jr. Familial high density lipoprotein deficiency: Tangier disease. In: Scriver CR Beaudet AL Sly WS Valle D , eds. Metabolic Basis of Inherited Disease, 6th edn. New York: McGraw Hill, 1989: 1267–82.

Teng B Sniderman AD Soutar AK Thompson GR. Metabolic basis of hyperapobetalipoproteinaemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolaemia. J Clin Invest 1986; 77: 663–72.

Goldstein JL Schrott HG Hazzard WR Bierman EL Motulsky AG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973; 52: 1544–68.

Davignon J Gregg RE Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1–21.

Fredrickson DS Morganroth J Levy RI. Type III hyperlipoproteinaemia. An analysis of two contemporary definitions. Ann Intern Med. 1975; 82: 150–7.

Eto M Watanabe K Ishii K. A rapid flat gel isoelectric focusing gel method for the determination of apolipoprotein E phenotypes and its application. Clin Chim Acta 1985; 149: 21–8.

McDowell IFW Wisdom GB Trimble ER. Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting. Clin Chem 1989; 35: 2070–3.

Houlston RS Snowden C Green F Alberti KGMM Humphries SE. Apolipoprotein (apo) E genotypes by polymerease chain reaction and allele-specific oligonucleotide probes: no detectable linkage disequilibrium between apoE and apoC-II. Hum Genet 1989; 83: 364–8.

Hixson JE Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res. 1990; 31: 545–8.

Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR Beaudet AL Sly WS Valle D , eds. Metabolic Basis of Inherited Disease, 6th edn. New York: McGraw Hill, 1989: 1165–80.

Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473–85.

Kane JP Hardman DA Paulus HE. Heterogeneity of apolipoprotein B: isolation of a new species from chylomicrons. Proc Natl Acad Sci USA 1980; 77: 2465–9.

Föger B Patsch JR. Strategies and methods for the assessment of disturbed postprandial lipid metabolism. Curr Opin Lipidol 1993; 4: 428–33.

Austin MA Breslow JL Hennekens CH Buring JE Willett WC Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 1988; 260: 1917–21.

Austin MA King M-C Vranizan KM Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495–506.

Galeano NF Milne RW Marcel YL Levy E McIntosh RA Curtin EL Does LDL size or lipid composition determine apoprotein B configuration and binding to the LDL receptor? Circulation 1989; 80 (Suppl II): 334.

Snowden C Houlston RS Arif MH Laker MF Humphries SE Alberti KGMM. Disparity between apolipoprotein phenotypes and genotypes (as determined by polymerase chain reaction and oligonucleotide probes) in patients with non-insulin dependent diabetes mellitus. Clin Chim Acta 1991; 196: 49–57.

Steinbrecher UP Witztum JL. Glucosylation of low density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 1984; 33: 130–4.

Lyons TJ Klein RL Baynes JW Stevenson HC Lopes-Virella MF. Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from Type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins. Diabetologia 1987; 30: 916–23.

Steinberg D Parthasarathy S Carew TE Khoo JC Witztum JL. Modifications of low density lipoprotein that increases its atherogenicity. N Engl J Med. 1989; 320: 915–24.

Schuh J Fairclough GF Jr Haschmeyer RH. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc Natl Acad Sci USA 1978; 75: 3173–7.

Cazzolato G Avogaro P Bittolo-Bon G. Characterisation of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Radic Biol Med. 1991; 11: 247–53.

Kane JP. Apolipoprotein B: structural and metabolic heterogeneity. Ann Rev Physiol 1983; 45: 637–50.

Knott TJ Rall SC Jr Innererity TL Jacobson SF Urdea MS Levy-Wilson B Human apolipoprotein B: structure of carboxy-terminal domains, sitess of gene expression, and chromosomal location. Science 1985; 230: 37–43.

Mehrabian M Sparks RS Mohandas T Klisak IF Schumaker VN Heinzman C Human apolipoprotein B: chromosomal mapping and DNA polymorphisms of hepatic and intestinal species. Somatic Cell Mol Genet 1986; 12: 245–54.

Ludwig EH Blackhart BD Pieroyyi VR Caiati L Fortier C Knott T DNA sequence of the human apolipoprotein B gene. DNA 1987; 8: 363–72.

Powell LM Wallis SC Pease RJ Edwards YH Knott TJ Scott J. A novel form of tissue-specific RNA processing produces apolipoprotein-B-48 in the intestine. Cell 1987; 50: 831–40.

Chen S-H Habib G Yang CY Gu Z-W Lee BR Weng S Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 1987; 238: 363–6.

Haddad IA Ordovas JM Fitzpatrick T Karathanasis SK. Linkage, evolution and expression of the rat apolipoprotein A-I, C-III, and apo A-IV genes. J Biol Chem 1986; 261: 13268–77.

Winkler KE Marsh JB. Metabolism of triglyceriderich nascent rat hepatic high density lipoproteins. J Lipid Res. 1989; 30: 989–96.

Ordovas JM Civeira F Genest J Schaefer EJ. Genetic high density lipoprotein deficiency states. Atheroscler Rev. 1990; 20: 261–72.

Milne RW Weech PK Marcel YL. Immunochemical methods for studying and quantifying lipoproteins and apolipoproteins. In: Converse CA Skinner ER , eds. Lipoprotein Analysis. A Practical Approach. Oxford: IRL Press, 1992: 61–84.

Marcovina SM Adolphson JL Parlavecchia M Albers JJ. Effects of lyophilization of apolipoproteins A-I and B. Clin Chem 1990; 36: 366–9.

Steinberg KK Cooper GR Graiser SR Rosseneu M. Some considerations of methodology and standardization of apolipoprotein A-I immunoassays. Clin Chem 1983; 29: 415–26.

Bury J Rosseneu M. Apolipoprotein quantitation by ELISA: technical aspects and clinical applications. Rev Immunoassay Tech 1988; 1: 1–25.

Ghosh DK Menon KMJ . Induction of high density lipoprotein receptors in rat corpus luteum by human choriogonadotrophin. Biochem J 1987; 244: 471–9.

Marcovina SM Albers JJ. Standardization of the immunochemical determination of apolipoproteins A-I and B: a report on the International Federation of Clinical Chemistry meeting on standardization of apolipoprotein A-I and B measurements (basis for future consensus), Vienna, Austria, April 18–19, 1989. Clin Chem 1989; 35: 2009–15.

Labeur C Shepherd J Rosseneu M. Immunological assays of apolipoproteins in plasma: methods and instrumentaion. Clin Chem 1990; 36: 591–7.

Lees RS. Immunoassay of plasma low density lipoproteins. Science 1970; 169: 493–4.

Sniderman A Teng B Jerry M. Determination of B protein of low density lipoprotein directly in plasma. J Lipid Res. 1975; 16: 465–7.

Albers JJ Wahl PW Cabana VG Hazzard WR Hoover JJ. Quantitation of apolipoprotein A-I of human plasma high density lipoprotein. Metabolism 1976; 25: 633–44.

Redman FC Vermond A. The quantitative determination of apolipoprotein A-I (apo-Ip-Gln I) in human serum by radial immunodiffusion assay (RID). Clin Chim Acta 1978; 87: 387–94.

Havekes L Hemmink J De Wit E. Low-density-lipoprotein apoprotein B in plasma as measured by radial immunodiffusion and rock Immunoelectrophoresis. Clin Chem 1978; 27: 1829–33.

Curry MD Gustafson A Alaupovic P McConathy WJ. Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. Clin Chem 1978; 24: 280–6.

Marcovina S Di Cola G Catapano AL. Radial immunodiffusion assay of apolipoprotein A-I with use of two monoclonal antibodies combined. Clin Chem 1986; 32: 2155–9.

Albers JJ Adolphson JL. Comparison of commercial kits for apoprotein A-I and apoprotein B with standardised apoprotein A-I and B radioimmunoassays performed at the Northwest Lipid Research Center. J Lipid Res. 1988; 29: 102–8.

Bachorik PS Cloey TA. Rate immunonephelometry and radial immunodiffusion compared for apolipoproteins A-I and B assay. Clin Chem 1989; 35: 2236–41.

Cooper GR Smith SJ Wiebe DA Kuchmak M Hannon WH. International survey of apolipoprotein AI and B measurements (1983–1984). Clin Chem 1985; 31: 223–8.

Richter W. Micromethod for immunochemical quantitation of dextran and studies on role of antigen size in single radial immunodiffusion. Inter Arch Allergy 1972; 43: 700–15.

Kahan J Sundblad L. Immunochemical determination of beta-lipoproteins. Scand J Clin Lab Invest 1969; 24: 61–8.

Curry MD Alaupovic P Suenram CA. Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. Clin Chem 1976; 22: 315–22.

Durrington PN Whicher JT Warren C Bolton CH Hartog M. A comparison of methods for the immunoassay of serum apolipoprotein B in man. Clin Chim Acta 1976; 71: 95–108.

Shapiro D Ballantyne FC Shepherd J. Comparison of immunonephelometry and electroimmunoassay for estimation of plasma apolipoprotein A-I. Clin Chim Acta 1980; 103: 7–13.

Miller JP Mao SJT Patsch JR Gotto AM Jr. The measurement of apolipoprotein A-I in human plasma by electroimmunoassay. J Lipid Res. 1980; 21: 775–80.

Vladutiu GD Glueck CJ Schultz MT McNeely S Guthrie R. Beta-lipoprotein quantitation in cord blood spotted on filter paper: a screening test. Clin Chem 1980; 26: 1285–90.

Fruchart JC Dulhilleul P Kora I Duquesne M Clavey V Gentilini JL. Rapid determination of human plasma apolipoprotein B. Clin Chim Acta 1981; 114: 123–6.

Rosseneu M Vinaimont N Vercaemst R De Keersgieter W Belpaire F. Standardisation of immunoaossays for the quantitation of plasma apo B protein. Anal Biochem 1981; 116: 204–10.

Weech PK. Electroimmunoassay rocket areas estimated with a desktop computer system: an expedient in the assay of serum apolipoproteins. Clin Chem 1981; 27: 357–8.

Reardon MF Poapst ME Uffelman KD Steiner G. Improved method for quantitation of B apoprotein in plasma lipoproteins by electroimmunoassay. Clin Chem 1981; 27: 892–5.

Meuffels MT Hindmarsh JT. Comparison of methods for the measurement of apoproteins A, and B in serum. Clin Biochem 1989; 22: 339–44.

Schonfeld G Lees R George PK Pfleger B. Assay of total plasma apolipoprotein B. Concentration in human subjects. J Clin Invest 1974; 53: 1458–67.

Albers JJ Cabana G Hazzard WR. Immunoassay of human plasma apolipoprotein B. Metabolism 1975; 24: 1339–51.

Fainaru M Glangeaud C Eisenberg A. Radioimmunoassay of human high density lipoprotein apoprotein A-I. Biochim Biophys Acta 1975; 386: 432–44.

Bedford DK Shepherd J Morgan HG. Radioimmunoassay for human plasma apolipoprotein B. Clin Chim Acta 1976; 70: 267–76.

Karlin JB Juhn DJ Starr JI Scanu AM Rubenstein AH. Measurement of human high density lipoprotein A-I in serum by radioimmunoassay. J Lipid Res. 1976; 17: 30–7.

Thompson GR Birnbaumer ME Levy RI Gotto AM Jr. Solid phase radioimmunoassay of apolipoprotein B (apoB) in normal human plasma. Atherosclerosis 1976; 24: 107–18.

Mao SJT Patton JG Badimon JJ Kottke BA Alley MC Cardin AD. Monoclonal antibodies to human plasma low-density lipoproteins. I. Enhanced binding of ¹²⁵I-labelled low-density lipoproteins by combined use of two monoclonal antibodies. Clin Chem 1983; 29: 1890–7.

Maynard Y Roden DC Tikkanen MJ Schonfeld G Ladenson JH. Radioimmunoassay of apolipoprotein B with use of monoclonal antibodies. Clin Chem 1984; 30: 1620–4.

Marcovina S Kottke BA Mao SJT. Monoclonal antibodies can precipitate low density lipoprotein. II. Radioimmunoasay with single and combined monoclonal antibodies for determining apolipoprotein B in serum of patients with coronary artery disease. Clin Chem 1985; 31: 1659–63.

Schonfeld G Patsch B Pfleger B Witztum JL Weidman SW. Lipolysis produces changes in the immunoreactivity and cell reactivity of very low density lipoproteins. J Clin Invest 1979; 64: 1288–97.

Mao SJT Kottke BA. Tween-20 increases the immunoreactivity of apolipoprotein A-I in plasma. Biochim Biophys Acta 1980; 620: 447–53.

Fruchart JC Desreumaux C Dewailly P Sezille G Jaillard J Carlier Y Enzyme immunoassay for human apolipoprotein B, the major protein moiety in low-density and very-low-density lipoproteins. Clin Chem 1978; 24: 455–9.

Holmquist L. Quantitation of human serum apolipoprotein B by enzyme immunoassay. Clin Chim Acta 1982; 121: 327–36.

Fievet C Koffigan M Ouvry D Marcovina S Moschetto Y Fruchart JC. Noncompetitive enzyme-linked immunoassay for apolipoprotein B in serum. Clin Chem 1984; 30: 98–100.

Bury J Rosseneu M. Quantification of human serum apolipoprotein AI by enzyme immunoassay. Clin Chem 1985; 31: 247–51.

Riesen WF Sturzenegger E Imhof C Mordasini R. Quantitation of apolipoprotein B by polyclonal and monoclonal antibodies. Clin Chim Acta 1986; 154: 29–40.

Young SG Smith RS Hogle DM Curtiss LK Witztum JL. Two new monoclonal antibody based enzyme-linked assays of apolipoprotein B. Clin Chem 1986; 32: 1484–90.

Dubois DY Cantraine F Malmendier CL. Comparison of different sandwich immunoassays for the quantitation of human apolipoproteins A-I and A-II. J Immunol Meth 1987; 96: 115–20.

Betard C Vu-Dac N Mezdour H Nestruck AC Leroy J Fruchart JC. Standardization of an enzymometric assay for apolipoprotein A-I by using mixtures of monoclonal antibodies. J Clin Chem Clin Biochem 1987; 25: 893–9.

Ordovas JM Peterson JP Santaniello P Cohn JS Wilson PWF Schaefer EJ. Enzyme linked immunosorbent assay for human plasma apolipoprotein B. J Lipid Res. 1987; 28: 1216–24.

Barkia A Martin C Puchois P Gwesquiere JC Cachera G Tartar A Enzyme linked immunosorbent assay for human proapolipoprotein A-I using specific antibodies against synthetic peptide. J Lipid Res. 1988; 29: 77–84.

Albers JJ Lodge MS Curtiss LK. Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100. J Lipid Res. 1989; 30: 1443–58.

Wang XL Dudman NPB Wilcken DEL. Enzyme-linked immunosorbent assay of apolipoprotein B in blood spotted onto filter paper, suitable for neonatal screening. Clin Chem 1989; 35: 1000–4.

Rifai N King ME. Immunoturbidometric assays of apolipoproteins A, AI, AII, and B in serum. Clin Chem 1986; 32: 957–61.

Riepponen P Marniemi J Rautaoja T. Immunoturbidometric determination of apolipoproteins A-I and B in serum. Scand J Lab Invest 1987; 47: 739–44.

Irish GR Ledue TB Barrantes DM. Measurement of apolipoprotein A-I in serum with the Technicon RA-1000 system. Clin Chem 1987; 33: 1266.

Mount JN Kearney EM Rosseneu M Slavin BM. Immunoturbidometric assays for serum apolipoproteins A-I and B using the Cobas Bio centrifugal analyser. J Clin Path 1988; 41: 471–4.

Brustolin D Maierna M Aguzzi F Zoppi F Taremghi G Berti G. Immunoturbidometric method for routine determinations of apolipoproteins A-I and B. Clin Chem 1991; 37: 742–7.

Ballentyne FC Williamson J Shapiro D Caslake MJ Perry B. Estimation of apolipoprotein B in man by immunonephelometry. Clin Chem 1978; 24: 788–92.

Fievet-Desreumaux C Dedonder-Decoopman E Fruchart JC Dewailly P Sezille G. Immunochemical determination of human apolipoprotein B by laser nephelometry. Clin Chim Acta 1979; 95: 405–8.

Hueck CC Schlierf G. Nephelometry of apolipoprotein B in human serum. Clin Chem 1979; 25: 221–6.

Lopes-Virella MFL Virella G Evans G Malenkos SB Colwell JA. Immunonephelometric assay of human apolipoprotein A-I. Clin Chem 1980; 26: 1205–8.

Fievet-Desreumaux C Dedonder-Decoopman E Dewailly P Sezille G. Immunochemical determination of human apolipoprotein A-I by laser nephelometry. Clin Chim Acta 1980; 107: 145–8.

Rosseneu M Vercaemst R Vinaimont N Van Tornout P Henderson LO Herbert PN. Quantitative determination of human plasma apolipoprotein A-I by laser immunonephelometry. Clin Chem 1981; 27: 856–9.

Rosseneu M Vinaimont N Vercaemst R De Keersgieter W Belpaire F. Standardisation of immunoassays for the quantitation of plasma apo B protein. Clin Chim Acta 1981; 116: 204–10.

Weinstock N Bartholome M Seidel D. Determination of apolipoprotein A-I by kinetic nephelometry. Biochim Biophys Acta 1981; 663: 279–88.

Wieland H Cremer P Seidel D. Determination of apolipoprotein B by kinetic (rate) nephelometry. J Lipid Res. 1982; 23: 893–902.

Kuusi T Palosuo T Ehnholm C. Immunonephelometric measurements of human plasma apolipoproteins A-I and A-II: an assay performed by consecutive addition of the two antisera to a single specimen. Scand J Clin Lab Invest 1985; 45: 245–53.

DaCol P Kostner GM. Immunoquantification of total apolipoprotein B in serum by nephelometry: influence of lipase treatment and detergents. Clin Chem 1983; 29: 1045–50.

Hallaway BJ Rastogi A Kottke BA. Apolipoprotein B quantified by particle-concentration fluorescence immunoassay. Clin Chem 1992; 38: 2387–91.

Smith SJ Cooper GR Henderson LO Hannon WH, the Apolipoprotein Standardization Group . An international collaborative study on standardization of apolipoproteins A-I and B. Part I. Evaluation of a lyophilized candidate reference and calibration material. Clin Chem 1987; 33: 2240–9.

Albers JJ Marcovina SM. Standardization of apolipoprotein B and A-I measurements. Clin Chem 1989; 35: 1357–61.

Albers JJ. The Apoprotein and Antibody Standardization Program Planning Committee. The apoprotein and antibody standardization program. Arteriosclerosis 1989; 9: 144–5.

Slater HR Tindle RW Packard CJ Shepherd J. A monoclonal-antibody-based immunoradiometric assay for apoprotein B in low-density lipoprotein. Clin Chem 1985; 31: 841–5.

Markwell MK Hass SM Bieber LL Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87: 206–10.

Henderson LG Powell MK Smith SJ Hannon WH Cooper GR Marcovina SM. Impact of protein measurements on standardization of apolipoproteins A-I and B. Clin Chem 1990; 36: 1911–17.

Marcovina SM Albers JJ Dati F Ledue TB Ritchie RF. International Federation of Clinical Chemistry Standardization Project for measurements of apolipoproteins A-I and B. Clin Chem 1991; 37: 1676–82.

Marcovina SM Albers JJ Henderson LO Hannon WH. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material. Clin Chem 1993; 39: 773–8.

Marcovina SM Albers JJ Kennedy H Mei JV Henderson LO Hannon WH. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of international reference material. Clin Chem 1994; 40: 586–92.

Marcovina SM Gaur VP Albers JJ. Biological variability of cholesterol, triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-I and B. Clin Chem 1994; 40: 574–8.

Lipid Research Clinics Program Epidemiological Committee. Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation 1979; 60: 427–39.

Heiss G Tamir I Davis CE Tyroler HA Rifkind BM Schonfeld G Lipoprotein-cholesterol distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation 1980; 61: 202–15.

Viikari J Rönnemaa T Seppänen A Marniemi J Porkka K Räsänen L Serum lipids and lipoproteins in children, adolescents and young adults in 1980–1986. Ann Med. 1991; 23: 53–9.

Donahue RP Jacobs DR Jr Sidney S Wagenknecht LE Albers JJ Hulley SB. Distribution of lipoproteins and apolipoproteins in young adults. The CARDIA study. Arteriosclerosis 1989; 9: 656–64.

Rosseneu M Vercaemst R Steinberg KK Cooper GR. Some considerations of methodology and standardization of apolipoprotein B immunoassays. Clin Chem 1983; 29: 427–33.

Azad K Court S Parkin JM Laker MF Alberti KGMM. Lipid levels in schoolchildren in North East England: effects of feeding and age. Ann Clin Biochem 1994; 31: 233–9.

Alaupovic P McConathy WJ Fesmire J Tavella M Bard JM. Profiles of apolipoproteins and apolipoprotein B-containing particles in dyslipoproteinemias. Clin Chem 1988; 34: B13–B27.

Zilversmit DB Shea TM. Quantitation of apoB-148 and apoB-100 by gel scanning or radio-iodination. J Lipid Res. 1989; 30: 1639–46.

Peel AS Zampelas A Williams CM Gould BJ. A novel antiserum specific to apolipoprotein B-48: application in the investigation of postprandial lipaemia in humans. Clin Sci. 1993; 85: 521–4.

Myant NB. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia. Atherosclerosis 1993; 104: 1–18.

Gaubatz JW Heidemann C Gotto AM Jr Morrisett JD Dahlen GH. Human plasma lipoprotein (a)—structural properties. J Biol Chem 1983; 258: 4582–9.

Utermann G Weber W. Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett 1983; 154: 357–61.

McClean JW Tomlinson JE Kuang W-J Eaton DL Chen EY Fless GM cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature (Lon) 1987; 330: 132–7.

Kratzin H Armstrong VW Niehaus M Hilschmann N Seidel D. Structural relationship of an apolipoprotein(a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol Chem Hoppe Seyler 1987; 368: 1533–44.

Koschinsky M Beisiegel U Henne-Bruns D Eaton DL Lawn RM. Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. Biochemistry 1990; 29: 640–4.

Utermann G Menzel HJ Kraft HG Duba HC Kemmler HG Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relationship to Lp(a) lipoprotein concentrations in plasma. J Clin Invest 1987; 80: 458–65.

Gaubatz JW Ghanem KI Guervera J Jr Nava ML Patsch W Morisett JD. Polymorphic forms of human apolipoprotein(a): inheritance and relationship of their molecular weights to plasma levels of lipoprotein(a). J Lipid Res. 1990; 31: 603–13.

Lackner C Boerwinkle E Leffert CC Rahmig T Hobbs HH. Molecular basis of apolipoprotein (a) isoform heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 1991; 87: 2153–61.

Albers JJ Hazzard WR. Immunochemical quantification of human plasma Lp(a) lipoprotein. Lipids 1974; 9: 15–26.

Gaubatz JW Cushing GL Morrisett JD. Quantitation, isolation, and characterisation of human lipoprotein(a). Methods Enzymol 1986; 129: 167–86.

Molinari E Pichler P Krempler F Kostner GA. A rapid screening method for pathological lipoprotein(a) concentrations by counterimmunoelectrophoresis. Clin Chim Acta 1983; 128: 373–8.

Albers JJ Adolphson JL Hazzard WR. Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res. 1977; 18: 331–8.

Fless GM Snyder ML Scanu AM. Enzyme-linked immunoassay for Lp(a). J Lipid Res. 1989; 30: 651–62.

Labeur C Michiels G Bury J Usher DC Rosseneu M. Lipoprotein(a) quantified by enzyme-linked immunosorbent assay with monoclonal antibodies. Clin Chem 1989; 35: 1380–4.

Rainwater DL Manis GS. Immunochemical characterisation and quantitation of lipoprotein (a) in baboons. Development of an assay depending on two antigenically distinct proteins. Atherosclerosis 1988; 73: 23–31.

Abe A Maeda S Makino K Seishima M Simokawa K Noma A Enzyme-linked immunosorbent assay of lipoprotein (a) in serum and cord blood. Clin Chim Acta 1988; 177: 31–40.

Vu-Dac N Mezdour H Parra HJ Luc G Luyeye I Fruchart JC. A selective bi-site immunoenzymatic procedure for human Lp(a) lipoprotein quantification using monoclonal antibodies against apo(a) and apoB. J Lipid Res. 1989; 30: 1437–43.

Wong WLT Eaton DL Berloi A Fendly B Hass PE. A monoclonal-antibody-based enzyme-linked immunosorbent assay of lipoprotein(a). Clin Chem 1990; 36: 192–7.

Taddei-Peters WC Butman BT Jones GR Venetta TM Macomber PE Ransom JH. Quantification of lipoprotein(a) particles containing various apolipoprotein(a) isoforms by a monoclonal anti-apo(a) capture antibody and a polyclonal anti-apolipoprotein B detection antibody sandwich enzyme immunoassay. Clin Chem 1993; 39: 1382–9.

Cazzolato G Prakasch G Green S Kostner GM. The determination of lipoprotein Lp(a) by rate and end-point nephelometry. Clin Chim Acta 1983; 135: 203–8.

Gillery P Arthuis P Cuperlier C Circaud R. Rate nephelometric assay of serum lipoprotein(a). Clin Chem 1993; 39: 503–8.

Albers JJ Marcovina SM Lodge MS. The unique lipoprotein(a): properties and immunochemical measurement. Clin Chem 1990; 36: 2019–26.

Seman LJ Jenner JL McNamara JR Schaefer EJ. Quantification of lipoprotein(a) in plasma by assaying cholesterol in lectin-bound plasma fraction. Clin Chem 1994; 40: 400–3.

Duvic CR Smith G Sledge WE Lee LT Murray MD Roheim PS Identification of a mouse monoclonal antibody, LHLP-1, specific for human Lp(a). J Lipid Res. 1985; 26: 540–8.

Guo H-C Armstrong VW Luc G Billardon C Goulinet S Nustede R Characterization of five mouse monoclonal antibodies to apolipoprotein(a) from human Lp(a). J Lipid Res. 1989; 30: 597–606.

Fless GM Rolih CA Scanu AM. Heterogeneity of human plasma lipoprotein(a). J Biol Chem 1984; 259: 11470–8.

Farrer M Game FL Adams PC Laker MF Alberti KGMM. A simple, sensitive technique for classification of apolipoprotein(a) isoforms by sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Clin Chim Acta 1992; 207: 215–25.

Hwang J Menon KMJ. Binding of apolipoprotein A-I and A-II after recombination with phospholipid vesicles to the high density lipoprotein receptor of luteinized rat ovary. J Biol Chem 1985; 260: 5660–8.

Barbaras R Puchois P Fruchart JC Ailhaud G. Cholesterol efflux from cultured adipose cells is mediated by LpA-I particles but not by LpA-I:A-II particles. Biochem Biophys Res Comm 1987; 142: 63–9.

Cheung MC Albers JJ. The measurement of apolipoproteins A-I and A-II levels in men and women by immunoassay. J Clin Invest 1977; 60: 43–50.

Albers JJ Cheung MC Wahl PW. Effect of storage on the measurement of apolipoproteins A-I and A-II by radial immunodiffusion. J Lipid Res. 1980; 21: 874–8.

Mao SJT Gotto AM Jr Jackson RL. Immunochemistry of human plasma high density lipoproteins. Radioimmunoassay of apolipoprotein A-II. Biochemistry 1975; 14: 4127–31.

Schonfeld G Chen J McDonnell WF Jeng I. Apolipoprotein A-II content of plasma high density lipoproteins measured by radioimmunoassay. J Lipid Res. 1977; 18: 645–54.

Mordasini RC Riesen WF. Electroimmunoassay and radioimmunoassay for the quantification of high density apolipoproteins A-I and A-II. J Clin Chem Clin Biochem 1980; 18: 917–20.

Dufaux B Ilsemann K Assmann G. Competitive enzyme immunoassay for apolipoprotein A-II. J Clin Chem Clin Biochem 1983; 21: 39–43.

Stein EA DiPersio L Pesce AJ Kashyap M Kao J-T Srivastava L Enzyme-linked immunosorbent assay of apolipoprotein AII in plasma, with use of monoclonal antibody. Clin Chem 1986; 32: 967–71.

Fruchart JC Ailhaud G. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. Clin Chem 1992; 38: 793–7.

Cheung MC Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography: particles containing AI and AII and particles containing AI but no AII. J Biol Chem 1984; 259: 12201–9.

Koren E Puchois P Alaupovic P Fesmire J Kandoussi A Fruchart JC. Quantification of two types of apolipoprotein A-I-containing particles in plasma by enzyme-linked differential-antibody immunosorbent assay. Clin Chem 1987; 33: 38–43.

Cheung MC Albers JJ. Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II. J Lipid Res. 1982; 23: 747–53.

Atmeh RF Shepherd J Packard CJ. Subpopulations of apolipoprotein A-I in human high density lipoproteins. Their metabolism, properties and response to drug therapy. Biochim Biophys Acta 1983; 751: 175–88.

Puchois P Kandoussi A Fievet P Fournier JL Bertrand M Koren E Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis 1987; 68: 35–40.

Breckenridge WC Little JA Steiner G Chow A Poapst M. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med. 1978; 298: 1265–73.

Curry MD McConathy WJ Fesmire JD Alaupovic P. Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays. Clin Chem 1981; 27: 543–8.

Jauhiaianen M Laitinen M Penttilä Puhakainen E Hietanen E. Determination of human apolipoprotein C-II by electroimmunoassay. Studies on standardization and determination before and after physical training. Int J Biochem 1983; 15: 501–6.

Kashyap ML Srivastava LS Chen C Perisutti G Campbell M Lutmer RF Radioimmunoassay of human apolipoprotein CII. J Clin Invest 1977; 69: 171–80.

Schonfeld G George PK Miller J Reilly P Witztum J. Apolipoprotein C-I and C-III levels in hyperlipoproteinemia. Metabolism 1979; 28: 1001–10.

Barr SI Kottke BA Chang JY Mao SJT. Immunochemistry of human plasma apolipoprotein C-II as studied by radioimmunoassay. Biochim Biophys Acta 1981; 663: 491–505.

Holmquist L. Quantitation of human serum very low density apolipoprotein B, C-I, C-II, C-III and E by enzyme immunoassay. J Immunol Meth 1980; 34: 243–51.

Bury J Michiels G Rosseneu M. Human apolipoprotein C-II quantitation by sandwich enzyme linked immunosorbent assay. J Clin Chem Clin Biochem 1986; 24: 457–61.

Poirer J Davignon J Bouthillier D Kogan S Bertrand P Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993; 342: 697–99.

Saunders AM Schmader K Breitner JCS Benson MD Brown WT Goldfarb L Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993; 432: 710–11.

Scott J. Apolipoprotein E and Alzheimer's disease. Lancet 1993; 432: 696.

Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622–30.

Davignon J Gregg RE Sing CF. Apolipoprotein polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1–21.

Steinmetz A Saile R Sefraoui M Parra HJ Fruchart JC. Confusion of apolipoprotein E phenotyping by serum amyloid. Clin Chem 1989; 35: 671–2.

Mailly F Davignon J Nestruck AC. Analytical isoelectric focusing with immobilised pH gradients of human apolipoprotein E from very low density lipoproteins and total plasma. J Lipid Res. 1990; 31: 149–55.

Luley C Baumstark MW Wieland H. Rapid apolipoprotein E phenotyping by immunofixation in agarose. J Lipid Res. 1991; 32: 880–3.

Wenham PR Sedky A Spooner RJ. Apolipoprotein phenotyping: a word of caution. Ann Clin Biochem 1991; 28: 599–605.

Weisgraber KH Newhouse YM Mahley RW. Apolipoprotein E genotyping using polymerase chain reaction and allele-specific oligonucleotide probes. Biochem Biophys Res Commun 1988; 157: 1212–7.

Emi M Wu LL Robertson MA Myers RL Hegele RA Williams RR Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988; 3: 373–9.

Green EK Bain SC Day PJ Barnett AH Charleson F Jones AF Detection of human apolipoprotein E3, E2 and E4 genotypes by allele-specific oligonucleotide-primed polymerase chain assay: development and validation. Clin Chem 1991; 37: 1263–8.

Wenham PR Newton CR Price WH. Analysis of apolipoprotein E genotypes by the amplification refractory mutation system. Clin Chem 1991; 37: 241–4.

Laker MF. Plasma lipids and lipoproteins in diabetes mellitus. In: Alberti KGMM Krall LP , eds. The Diabetes Annual 2. Amsterdam: Elsevier, 1986: 267–82.

Kushwaha RS Hazzard WR. Type III hyperlipoproteinemia: diagnosis in whole plasma by apolipoprotein immunoassay. Ann Intern Med. 1977; 87: 509–16.

Curry MD McConathy WJ Fesmire JD Alaupovic P. Determination of human apolipoprotein E by electroimmunoassay. Biochim Biophys Acta 1976; 439: 413–25.

Blum CB Aron L Sciacca R. Radioimmunoassay studies of human apolipoprotein E. J Clin Invest 1980; 66: 1240–50.

Mackie A Caslake MJ Packard CJ Shepherd J. Concentration and distribution of human plasma apolipoprotein E. Clin Chim Acta 1981; 116: 35–45.

Au YPT Bren ND Kottke BA. A rapid apolipoprotein E radioimmunoassay using solid-phase Staphylococcus protein. Use of pooled plasma as a secondary standard. Biochem Biophys Res Commun 1986; 138: 455–62.

Bury J Vercaemst R Rosseneu M Belpaire F. Apolipoprotein E quantified by enzyme-linked immunosorbent assay. Clin Chem 1986; 32: 265–70.

Alsayed N Rebourcet R Chapman J. Concentrations of apoprotein CII, CIII and E in total serum and in the apoprotein B-containing lipoproteins, determined by a new enzyme-linked immunosorbent assay. Clin Chem 1990; 36: 2047–52.

Weisweiler P Schwandt P. Immunonephelometric quantitation of apolipoprotein E in human serum. J Clin Chem Clin Biochem 1983; 21: 227–30.

Rifai N Silverman LM. A simple immunotechnique for the determination of serum concentration of apolipoprotein E. Clin Chim Acta 1987; 163: 207–13.

Evans K Laker MF. Intra-individual factors affecting lipid, lipoprotein and apolipoprotein measurement: a review. Ann Clin Biochem 1995; 32: 261–80.

Cohn JS McNamara JR Cohn SD Ordovas JM Schaefer EJ. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res. 1988; 29: 469–79.

Azad K Court S Parkin JM Laker MF Alberti KGMM. Lipid levels in schoolchildren in North East England: effects of feeding and age. Ann Clin Biochem 1994; 31: 233–9.

Rifai N Merrill R Holly RG. Postprandial effect of a high fat meal on plasma lipid, lipoprotein cholesterol and apolipoprotein measurements. Ann Clin Biochem 1990; 27: 489–93.

Edelstein C Gordon JI Poscas K Sims HF Strass AW Scanu AM. In vitro conversion of proapoprotein A-I to apoprotein A-I. J Biol Chem 1983; 258: 11430–3.

Hankinson SE London SJ Chute CG Barbieri RL Jones L Kaplan LA Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem 1989; 35: 2313–16.

Evans K Mitcheson J Laker MF. Effect of storage at 4°C and −20°C on lipid, lipoprotein and apolipoprotein concentrations. Clin Chem (in press).

Sgoutas DS Tuten T. Effect of freezing and thawing of serum on the immunoassay of lipoprotein(a). Clin Chem 1992; 38: 1873–7.

Hofmann AF. The aminopyrine demethylation breath test and serum bile acid level: nominated but not yet elected to join the common liver tests. Hepatology 1982; 2: 512–17.